The SEAB is a consultative body which is formed to ensure and improve the scientific performance and the quality of results of BetaCure. The members of the SEAB will monitor the progress of work, assess the scientific quality and give feed-back to the Consortium members. The Board will also fulfil the tasks of the Data Safety Monitoring Board. The SEAB will also consider and mention any ethical issues which might require (stronger) attention in their feed-back.

 

  • Bernd Pichler, Professor,
    Chair of the Laboratory for Preclinical Imaging and Imaging Technology of the Werner Siemens Foundation, University of Tuebingen, Germany
     
  • Stephan Speier, PhD
    PhD, Chair of the Islet Regeneration Laboratory, Centre of Regenerative Therapies Dresden, Technical University Dresden, Germany
     
  • Ulrike Seyfarth
    Chair “Kongenitaler Hyperinsulinismus e.V.” (German patient organization for CHI), Berlin, Germany
     
  • Adrienne Burton
    Children´s Hyperinsulinism Fund, London, UK
     
Print
Top
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Until you give your consent, only those cookies necessary to maintain the website's functionality are active. When you choose "OK", so called third-party non-functional cookies (e.g. GDPR-conform Google Analytics) may also become active. Please be aware that the website's functionality may be restricted if you choose "DECLINE". You can revoke your choice at any time by clearing your browser cache/history and updating your selection. Please also view our privacy policy.
Ok Decline